Blauwet MB

ORCID: 0000-0002-5719-7479 · 1 paper in corpus

2020

Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.

Journal of pain research ·doi:10.2147/jpr.s274562

PurposeASP0819 is a novel, non-opioid KCa3.1 channel opener that reverses abnormal nerve firing of primary sensory afferent nerves. Currently available treatments for fibromyalgia provide only modest relief and are accompanied by a host of …